Pulmonary Fibrosis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Pulmonary Fibrosis stocks.

Pulmonary Fibrosis Stocks Recent News

Date Stock Title
Aug 1 BIIB Biogen (BIIB) Q2 2024 Earnings Call Transcript
Aug 1 BIIB Biogen Inc. (BIIB) Q2 2024 Earnings Call Transcript
Aug 1 BIIB Biotech Stock Roundup: BMY, GSK, BIIB's Q2 Results, VTVT Down on Setback
Aug 1 BIIB Biogen (BIIB) Q2 Earnings & Sales Beat, 2024 Guidance Raised
Aug 1 BIIB Sage Therapeutics (SAGE) Q2 Loss Wider Than Expected, Sales Rise
Aug 1 BIIB Biogen Q2 Earnings: Beats Consensus, Lifts 2024 Profit Forecast As New Drug Launches Expected To Offset Decline In Multiple Sclerosis Med Sales
Aug 1 BIIB Biogen Stock Slips As Alzheimer's Drug Looks Abroad For Quarterly Beat
Aug 1 BIIB Biogen Lifts Earnings Guidance After Revenue Beats Forecasts
Aug 1 BIIB Biogen (BIIB) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Aug 1 BIIB Biogen posts Q2 beat as sales from Alzheimer’s drug pick up
Aug 1 BIIB Biogen Inc. 2024 Q2 - Results - Earnings Call Presentation
Aug 1 BIIB Biogen Inc. (BIIB) Q2 Earnings and Revenues Top Estimates
Aug 1 BIIB Meta Platforms, Ferrari, ConocoPhillips rise premarket; Arm, Moderna fall
Aug 1 BIIB Wall Street Looks To Ride On Earnings Cheer As Meta Q2 Impresses Investors: Analyst Says Economic Data, Stock Performances Suggest Republican Win In November
Aug 1 TRVI Trevi Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on August 8, 2024
Aug 1 BIIB Biogen Non-GAAP EPS of $4.02 misses by $0.01, revenue of $2.46B beats by $70M
Aug 1 BIIB Biogen lifts profit forecast, signals progress in turnaround effort
Aug 1 BIIB As sales climb, Biogen ‘convinced’ the worst is over for Leqembi
Jul 31 BIIB Biogen Q2 2024 Earnings Preview
Jul 31 FGEN FibroGen axes 75% of staff after lead cancer therapy fails in Phase III trials
Pulmonary Fibrosis

Pulmonary fibrosis is a condition in which the lungs become scarred over time. Symptoms include shortness of breath, a dry cough, feeling tired, weight loss, and nail clubbing. Complications may include pulmonary hypertension, respiratory failure, pneumothorax, and lung cancer.Causes include environmental pollution, certain medications, connective tissue diseases, infections (including SARS infections), interstitial lung diseases. Idiopathic pulmonary fibrosis (IPF), an interstitial lung disease of unknown cause, is most common. Diagnosis may be based on symptoms, medical imaging, lung biopsy, and lung function tests.There is no cure and there are limited treatment options available. Treatment is directed towards efforts to improve symptoms and may include oxygen therapy and pulmonary rehabilitation. Certain medications may be used to try to slow the worsening of scarring. Lung transplantation may occasionally be an option. At least 5 million people are affected globally. Life expectancy is generally less than five years.

Browse All Tags